| Chemical class | Inorganic salt (cyanide compound) | Barbiturate (organic sedative-hypnotic) |
| Primary legitimate uses | Industrial chemistry, metallurgy, electroplating, gold mining, laboratory reagent | Medical sedation, anesthesia, seizure control, veterinary euthanasia |
| Medical use | ❌ No therapeutic medical use | ✅ Yes (human & veterinary medicine, controlled) |
| Mechanism of toxicity | Blocks cellular respiration by inhibiting cytochrome c oxidase → cells cannot use oxygen | Depresses central nervous system by enhancing GABA activity → sedation, respiratory depression |
| Primary system affected | Cellular metabolism (system-wide) | Brain and respiratory centers |
| Onset of effects | Very rapid due to cellular hypoxia | Gradual CNS depression |
| Reversibility | Limited without immediate antidotal treatment | Potentially reversible with supportive care (depends on context) |
| Antidote availability | Yes (specific cyanide antidotes exist) | No specific antidote (supportive care only) |
| Regulatory status | Strictly regulated industrial poison | Controlled drug (prescription-only / veterinary use) |
| Ethical & legal context | Associated with chemical hazards and historical misuse | Used in medicine; ethically regulated in end-of-life laws in some countries |
| Risk profile | Extremely dangerous, small handling errors can be fatal | Dangerous in misuse but designed for controlled clinical settings |